Featured Slider

As it has done globally for the past 18 months, COVID-19 attracted plenty of attention on Saturday, in the first Special Session of EAN 2021, as experts from a range of backgrounds addressed the impact and outcomes of the pandemic from a variety of perspectives.  … Continue Reading

The seventh EAN congress officially got under way on Friday, June 18, with the meeting’s first plenary symposium, the Opening Session, marking the start of the academy’s second virtual congress. Following a year of continued challenges since the previous congress, EAN has adapted further to the ongoing global circumstances and—drawing on… Continue Reading

Dr Tom Jenkins, Editor-in-chief, EAN website Professor Claudio Bassetti introduced the Five Presidents Symposium on sleep disorders on Saturday morning, co-chaired with Professor Ulf Kallweit, with lectures given by the presidents of five major neurological associations: Professor James Stevens, past… Continue Reading

Dr Tom Jenkins, Editor-in-chief, EAN website We are proud to present the launch of 45,000 Brains at our Congress this year.  This is a new forum for neurologists in the EAN to discuss difficult cases on the EAN website. The… Continue Reading

As Chair of the Programme Committee, I cannot wait to see the culmination of the hard work that has gone into putting this congress together, both in terms of content and organisation, building on the success of last year.

Prof. Carlos Rieder, President of the Brazilian Academy of Neurology is interviewed by Prof. D. Muresanu and Prof. T. von Oertzen, co-chairs of the EAN Communication Committee

For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

Jes Olesen, winner of the 2021 Brain Prize I am very pleased to be asked for an interview on the occasion on my receipt of The Brain Prize. EAN is very close to my heart and I regard it as… Continue Reading

For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

Individual registration for the EAN 2021 Congress is now back online, with a 10% discount available until May 10!

Executive Page: Antonella Macerollo as Editor of EANpages

Paper of the month: Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin

Executive Page from Professor Bassetti

For March 2021, we have selected: Lynch D.R. et al. Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol 2021; 89:212-225. doi: 10.1002/ana.25934.

Country of the Month for March 2021 is Lithuania